Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institut…
$218.03+1.08%
报价 2026-11-13
市值
$59.39B
EV
$75.12B
PE (TTM)
25.3x
预期 PE (FY2027)
16.4x
52 周区间距高点 0.0%
$140.71$218.03
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22028-09 | 1.0x | 12.57 → 14.23(1.1x) | 15.3 |
| FY+32029-09 | 1.1x | 12.57 → 15.27(1.2x) | 14.3 |
毛利率 46% · TTM 收入 $20223M · 基数 EPS 12.57(调整后)
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BDXBecton, Dickinson and Company | $59.39B | +1.1% | +2.4% | 45.8% | 25.3x | 14.7x | 21.1x | |
| CAHCardinal Health, Inc. | $64.97B | +1.1% | +4.1% | 4.3% | 31.6x | 16.9x | 11.9x | |
| EWEdwards Lifesciences Corporation | $61.61B | +1.3% | +12.7% | 78.1% | 44.5x | 32.6x | 43.3x | GARP |
| ARGXargenx SE | $60.37B | -2.2% | – | 89.9% | 38.2x | 39.0x | 58.5x | |
| IDXXIDEXX Laboratories, Inc. | $55.48B | +0.9% | +10.8% | 62.9% | 47.6x | 33.7x | 42.8x | |
| AAgilent Technologies, Inc. | $49.05B | +0.5% | +6.5% | 26% | 27.1x | 23.0x | 34.2x | |
| VEEVVeeva Systems Inc. | $48.82B | -0.3% | +16.5% | 75% | 48.9x | 36.6x | 29.9x | |
| IQVIQVIA Holdings Inc. | $43.69B | -2.2% | +8.0% | 32.9% | 33.1x | 16.6x | 16.9x | |
| HLNHaleon plc | $40.25B | +0.9% | – | 61.8% | 21.8x | 14.3x | – | |
| 同行中位数 | – | – | +9.4% | 62.4% | 35.6x | 27.8x | 34.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。